Mark Ebbert, PhD, an Assistant Professor of Neuroscience with the Mayo Clinic. He received a 2017 Research Starter Grant in Translational Medicine and Therapeutics. Dr. Ebbert’s research is focused strongly on Alzheimer’s and helping medicine better understand the origins of this deadly disease.
Dr. Ebbert and his co-authors recently published new research on camouflaged genes that could impact neurological diseases such as Alzheimer’s. You can read the article in the journal Genome Biology.
Watch a short video in which Dr. Ebbert discusses the impact of the PhRMA Foundation on his work here.